Comparing ATRT, DIPG and ETMR Pediatric Brain Tumors

Pediatric brain tumors are the second most commonly diagnosed cancer in children, and the second leading cause of cancer death among children and infants. Despite significant improvements in outcomes for some pediatric cancers, when current treatments such as chemotherapy, surgery, or radiotherapy fail, there is still an unacceptably low chance of survival, in part because the most current and innovative research is prioritized for adults.

While there are many different types of brain tumors that affect children, rare brain tumors are often the most difficult to treat, in part because so little research has been done on them, and because they are typically more fast-growing and aggressive.

A little girl is sitting in a crib in a hospital room.

Rare Brain Tumors in Children

The following rare brain tumors are among those with the lowest survival rates, but with new clinical trial funding, these toughest of childhood brain tumors can be studied and treated more successfully:

    • Atypical Teratoid Rhabdoid Tumors (ATRT)

    • Diffuse Intrinsic Pontine Glioma Tumors (DIPG)

    • Embryonal Tumors with Multilayered Rosettes (ETMR)

 

Atypical Teratoid Rhabdoid Tumor (ATRT)

Atypical Teratoid Rhabdoid Tumors are very aggressive tumors that occur in the central nervous system and generally form in the cerebellum or brainstem. ATRTs are typically associated with an abnormality in a specific gene that helps prevent tumor growth in the body.

    • Grade IV: the most aggressive

    • Occurs in the cerebellum or brainstem
    • 
Presents in less than 3% of pediatric brain tumors
    • 
Usually develops by age three but can occur in older children
    • 
Existing treatments include surgery, chemotherapy, and radiation

ATRT Symptoms
    • 
Headaches, particularly in the morning or that subside after vomiting
    • 
Fatigue, extreme tiredness
    • 
Nausea and vomiting
    • 
Twitches or unusual facial or eye movements
    • 
Issues with balance, coordination, or walking
    • 
Changes in behavior or personality
    • 
Hydrocephalus (swelling of the head due to fluid build-up around the brain) in infants

ATRT Treatments
Treatments for ATRT can vary for each person based on the characteristics, location, and grade of the tumor. Often, the cancer is treated with a combination of existing treatments.

Surgery: Surgery is often the first treatment used to both confirm the ATRT tumor type and attempt to safely remove as much of the tumor as possible. Depending on the location of the tumor and how widespread it is, surgery may not be possible to remove the tumor without damaging other parts of the brain.

Chemotherapy: Chemotherapy is often used in combination with surgery to prevent additional growth and spread of the tumor.

Radiation: Radiation uses high blasts of radiation waves to precisely target ATRT and can be used in conjunction with chemotherapy to target cancer cells after surgery. However, it is not typically used in children under three years of age due to its intensity and possible damage to nearby tissues around the tumor.

 

Diffuse Intrinsic Pontine Glioma (DIPG)

Diffuse Intrinsic Pontine Glioma Tumors are located in the pons (middle) of the brainstem. DIPG tumors are incredibly difficult to treat due to their location in the brainstem, which controls many important functions such as breathing, blood pressure, and heart rate.
    • 
Usually Grade III or IV by diagnosis
    • 
Occurs in the brainstem/pons
    • 
Presents in 10-20% of children with brain tumors
    • 
Usually develops between ages five and 10 but can occur in older children
    • 
Existing treatments include chemotherapy and radiation

DIPG Symptoms
    • 
Weakness in arms and legs
    • 
Facial weakness and drooping
    • 
Problems with chewing and swallowing
    • 
Vision changes/eye movements, such as double/blurred vision and uncontrolled movements
    • 
Headaches, particularly in the morning or that subside after vomiting
    • 
Nausea and vomiting
    • 
Issues with balance, coordination or walking
    • 
Changes in behavior or personality; irritability, aggravation, anxiety

DIPG Treatment

Radiation: Unfortunately, radiation therapy is one of the only effective treatments used to shrink DIPG tumors in children older than three years of age. Surgery is not possible without the great risk of damaging key parts of the brainstem. While chemotherapy is sometimes used in conjunction with radiation, there is little evidence, to date, to support that it increases the overall survival rate.

 

Embryonal Tumors with Multilayered Rosettes (ETMR)

Embryonal Tumors with Multilayered Rosettes are very aggressive tumors that usually form in the largest part of the brain, the cerebrum. These tumors develop from embryonic cells that remain in the brain after the child has been born and are the rarest of infant and childhood brain tumors with the lowest survival rate.
    • 
Usually Grade IV
    • 
Typically occurs in the cerebrum but can be found in the brainstem or spinal cord
    • 
Accounts for 2% of pediatric brain tumors
    • 
Develops in infants and children under four years of age
    • 
Existing treatments include surgery, chemotherapy, radiation

ETMR Symptoms
    • 
Muscular weakness or partial paralysis of facial muscles or one side of the body
    • 
Loss of balance, trouble walking, lack of coordination, or slow speech
    • 
Seizures
    • 
Headaches, particularly in the morning or that subside after vomiting
    • 
Nausea and vomiting
    • 
Unusual sleepiness or change in energy level
    • 
Double vision or other eye problems
    • 
Changes in behavior or personality; irritability, aggravation, anxiety

ETMR Treatments

Surgery: Typically, surgery to remove, partially remove or biopsy the tumor is the first course of action for ETMR.

Chemotherapy: Chemotherapy is usually recommended after surgery to target any remaining cancer cells.
Radiation: Radiation is often one of the most effective treatments for children with ETMR. However, radiation can also have long-term devastating effects on the developing brain, so physicians will consider the patient’s age, the location of the tumor and the tumor type before determining to use radiation as a treatment option.

 

Funding new treatments

Despite major improvements in childhood cancer therapies and survival rates, pediatric brain tumors like ATRT, DIPG, and ETMR are the toughest to treat and overcome, even with a combination of the most aggressive traditional treatments. At Solving Kids’ Cancer, we believe that clinical trials of new therapies are vital to continuing the fight against these devastating childhood cancers.

We prioritize and fund innovative preclinical research and early phase clinical trials with strong rationale for potential benefit to children with poor prognosis cancers. Through collaboration with key stakeholders including scientists, clinicians, regulatory experts, and industry representatives, we aim to accelerate impactful advances globally.

Our projects like Can Nivolumab Treat Childhood Brain Tumors? and Immunotherapy for Relapsed and Refractory Pediatric Brain Tumors have helped to expand possible treatment options for children with the worst of the worst childhood cancers. With a focus on innovative treatments, such as immunotherapy, and collaboration across the globe, Solving Kids’ Cancer has funded work in more than 110 cancer centers across 15 countries to date. Funded projects include 14 international studies and represent collaborations with 20 different charity partners.

Pushing the limits of innovation can change the world for children with rare pediatric brain tumors. May is Brain Tumor Awareness Month. Your gift to Solving Kids’ Cancer provides kids with brain tumors and their families hope of discovering better treatment options — because every kid deserves to grow up®.

A pink button that says `` fund a treatment '' on a white background.
A man and a little girl are sitting in front of a wooden wall.
By duda November 20, 2024
Ahana’s Story of Strength with High-Risk Neuroblastoma Every day, over 1,000 children worldwide are diagnosed with cancer,1 and for many families, that diagnosis means facing an uncertain future. At just 20 months old, Ahana was diagnosed with a rare and aggressive cancer that had already spread through her small body. Her family’s search for life-saving childhood cancer treatments led them from South Africa to Spain and possibly toward a clinical trial in New York. Ahana’s journey shows the importance of supporting organizations like Solving Kids’ Cancer, which works to find, fund, and advocate for advanced treatments that give hope to families fighting against tough-to-treat rare pediatric cancers.
A poster for 2024 year in review for solving kids ' cancer
November 11, 2024
Advancing Childhood Cancer Research: SKC’s 2024 Milestones
A group of children are holding a sign that says
October 1, 2024
Lace Up for Kids: Your Impact on Childhood Cancer Research At Solving Kids’ Cancer, our mission has always been driven by hope — hope for better treatments, hope for breakthroughs, and most importantly, hope for every child fighting cancer. This year’s Lace Up for Kids campaign was nothing short of inspiring. Together, we’ve raised over $264,000 across the entire campaign, funding innovative childhood cancer research and providing more treatment options for children in need.  From coast to coast, nearly 4,000 participants have stepped up to lace up their gold shoelaces and make a difference. Whether it was through schools, sports teams, or community groups, the show of support has been overwhelming throughout the years. Over 7,823 donations have been made to accelerate new treatments, and the hashtag #CareWearShare has been used 13,864 times, spreading the message far and wide!
A girl is standing in front of a car in a parking lot.
September 2, 2024
Gold Laces for Childhood Cancer Awareness Month: Erin’s Story 
A group of children are standing in a circle with their shoes on the floor.
August 8, 2024
Smithtown Goes Gold for Childhood Cancer Awareness Month!
A poster for lace up for kids with a butterfly on it
August 6, 2024
Childhood Cancer Awareness Month: Lace Up for Kids 2024
A man standing on top of a mountain with the words osteosarcoma survivor to surgeon dr. kurt weiss ' story
August 1, 2024
Osteosarcoma Survivor to Surgeon: Dr. Kurt Weiss’ Story
Jacob 's journey : a childhood cancer survivor 's story
May 10, 2024
Jacob’s Journey: A Childhood Cancer Survivor’s Story Every battle has its heroes, and among the bravest are young children like Jacob Mozer, who faced stage 4 high-risk neuroblastoma when he was barely old enough to walk. Diagnosed at only 16 months old, Jacob’s early years were filled with constant medical appointments and intense treatments. Despite these challenges, today, Jacob is a shining example of the remarkable progress in pediatric oncology. He’s not merely surviving; he’s thriving as a pharmacy resident, driven to give back to the medical community that gave him a second chance at life. During National Cancer Survivors Month this June, we honor and celebrate fighters like Jacob who have battled cancer and emerged stronger. This month also serves to amplify the conversation about pediatric cancer survivorship and push for vital research that continues to save lives. Solving Kids’ Cancer (SKC) plays an essential role in this effort, supporting children like Jacob by funding crucial clinical trials that enhance survival rates and improve the quality of life for those fighting fatal childhood cancers.
A close up of a person holding a test tube in a laboratory.
May 2, 2024
Trailblazing Treatments for Pediatric Brain Tumors Picture a fortress built to guard precious treasure but accidentally also keeps out the very allies it needs in a time of crisis. This is the challenge faced by medical researchers when dealing with the brain’s natural defense — the blood-brain barrier — especially in children with brain tumors. At Columbia University Medical Center, Dr. Luca Szalontay is leading the charge to breach this fortress with groundbreaking approaches. Recently, Dr. Timothy Cripe from Solving Kids’ Cancer’s podcast, This Week in Pediatric Oncology (TWIPO) , interviewed Dr. Szalontay to delve deeper into these innovative treatments. This Brain Tumor Awareness Month, we’re shining a light on these important advances in treating children’s cancer. Understanding the Challenge Treating pediatric brain tumors like diffuse midline glioma (DMG) is especially tough because of the brain’s own protective shield, known as the blood-brain barrier. This barrier keeps out most chemotherapy drugs as well as large molecules, like antibodies, making it hard to treat the tumors effectively. Dr. Szalontay describes the dilemma: “Our field hasn’t been able to advance as quickly as it has with leukemias or other solid tumors because the drugs don’t penetrate the brain efficiently.” She adds on the nature of this blood-brain barrier, “It’s evolutionary, very important to protect us from different toxins and harmful agents, but this is a shield which protects the tumor as well.” Even when drugs work well in lab tests, they struggle to get to the tumor in strong enough doses without harming the body. Dr. Szalontay also points out that DMG tumors are found in very sensitive areas of the brain, making traditional surgery or radiation risky because they could damage vital brain functions. This makes finding safe and effective treatments for these tumors even more challenging. So, what’s being done to tackle these obstacles and help kids fight these tumors?
A group of stick figures are holding hands around a globe.
April 4, 2024
World Health Day: Pediatric Cancer’s Global Divide Imagine this: Two children, born at the same moment, oceans apart. In a country brimming with medical resources, one child quickly gets top-notch treatment for cancer. Meanwhile, across the globe, the other child faces a drastically different reality, with limited access to basic care. This isn’t just a thought experiment — it’s the harsh truth of pediatric cancer treatment worldwide. Observed every year on April 7, World Health Day shines a light on the mission to make healthcare accessible for all. This day is particularly significant in the context of pediatric cancer, where vast disparities in treatment availability highlight the global challenge of ensuring every child has the opportunity for health and healing. The Stark Contrast in Survival Rates: A Look at Pediatric Cancer Statistics Every day, more than 1,000 children are diagnosed with cancer, and the chances of survival vary greatly depending on where they live.1 Pediatric cancer survival rates serve as a clear indicator of the disparities between high-income countries (HICs) and low- and middle-income countries (LMICs). In wealthier nations such as the United States and Western Europe, the 5-year survival rate for children with cancer is over 80%, thanks to advanced healthcare systems and access to the latest treatments.2 But, here’s a troubling childhood cancer statistic: in LMICs where 80% of children with cancer live, fewer than 20% survive.1 This gap is due to several factors, including late diagnoses or, tragically, no diagnosis at all. Many children succumb to the disease without access to pain medication, and the burdens of travel and the high costs force most families to abandon care. These challenges are compounded by limited access to necessary treatments,3 as well as a lack of specialized equipment and trained healthcare professionals needed for effective pediatric cancer treatment. Addressing this divide requires a concerted global effort to improve early detection, make treatments more affordable, and enhance healthcare infrastructures, giving every child a fair chance to beat cancer. Navigating the Access Maze Access to cancer care shouldn’t be a treasure hunt. Yet, for many in LMICs, it feels like that — a relentless search for something seemingly out of reach. Here’s the reality revealed in childhood cancer statistics worldwide: many areas lack enough doctors who specialize in children’s cancer4 and the prices of cancer drugs can be sky-high.2 Even getting to a hospital can be an ordeal, with some families traveling hundreds of miles. And the financial strain? Devastating. The cost of care can quickly add up to more than a year’s income, forcing households into deep financial distress. In many LMICs, the lack of comprehensive insurance coverage means families are often left to pay for pediatric cancer treatment entirely out-of-pocket.5 Families often face the impossible choice between their child’s health and their financial survival. Solving Kids’ Cancer: Bridging the Gap Solving Kids’ Cancer (SKC) isn’t standing by; we’re on the front lines, actively working to make a difference in the global pediatric cancer landscape. Beyond funding research, advocating for policy changes, and fostering global partnerships, SKC is committed to educating and empowering the community to take action. We understand that while we might not have a global foothold to address every aspect of the pediatric cancer divide directly, there’s power in collective action. Through our efforts, we aim to catalyze advancements in pediatric cancer treatments and care that could dramatically change outcomes for children worldwide. • Research: We direct funds into cutting-edge studies, searching for breakthrough treatments that promise a brighter future for all kids, regardless of where they live. • Advocacy: We advocate for children’s needs by steering research funding towards unmet challenges and collaborating with experts to prioritize all children, including expanding trials to international sites to maximize access.2 • Global Partnerships: We don’t do it alone. By teaming up with researchers, hospitals, and other organizations across the globe, we’ve helped fund clinical trials that have extended to over 250 institutions across 15 countries worldwide . Uniting for a Cause Solving Kids’ Cancer extends its mission beyond research by fostering community and collaboration. Our signature event, Lace Up for Kids , held annually during September Childhood Cancer Awareness Month, is a powerful testament to this mission, drawing communities together to stand in solidarity against childhood cancer. Additionally, supporters can create their own fundraiser and have a platform to engage their local communities, sparking crucial conversations and garnering support for the cause. These initiatives highlight an important fact: While the challenge of pediatric cancer is significant, each of us has a part to play. By working together and supporting each other, we can fund the research needed to possibly change the direction of pediatric cancer treatment and care worldwide. World Health Day: A Chance for Every Child The fight against pediatric cancer is a stark reminder of the work ahead of us.6 It’s a battle that Solving Kids’ Cancer is dedicated to, but we need more than just our efforts — we need a global movement. This World Health Day, let’s rally for every child’s right to fight cancer on an even playing field. Donate today to help fund more innovative research and one day find a cure for childhood cancer — because every child, no matter where they are born, deserves a chance — a chance to fight, a chance to survive, and a chance to thrive.
More Posts